Trials / Sponsors / TNF Pharmaceuticals, Inc.
TNF Pharmaceuticals, Inc.
Industry · 4 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | Safety and Efficacy of Isomyosamine in Reducing Inflammation and Treating Muscle Loss in Older Adults After Hi Sarcopenia in Elderly, Frailty, Frailty/Sarcopenia | Phase 2 | 2025-05-01 |
| Completed | Evaluation of Efficacy, Tolerability, and Pharmacokinetics of MYMD1 for Chronic Inflammation and Sarcopenia/Fr Sarcopenia, Frailty, Aging | Phase 2 | 2022-02-01 |
| Completed | Single Ascending and Multiple Dose Study to Evaluate Safety, Tolerability, and PK of MYMD1 in Healthy Male and Hashimoto Disease | Phase 1 | 2021-04-26 |
| Completed | Single Ascending-dose Study to Evaluate Safety, Tolerability, and PK of MYMD1 in Healthy Male Adult Subjects Undefined | Phase 1 | 2019-06-11 |